Nature 1980, 284:67–68 PubMedCrossRef 33 Hofmann UB, Westphal JR

Nature 1980, 284:67–68.PubMedCrossRef 33. Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ: Matrix metalloproteinases in human melanoma. S63845 J Invest Dermatol 2000, 115:337–344.PubMedCrossRef 34. Cáceres M, Guerrero J, Martínez J: Overexpression of RhoA-GTP induces activation

of the epidermal growth factor receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells. Exp Cell Res 2005, 309:229–238.PubMedCrossRef 35. Danker K, Mechai N, Lucka L, Reutter W, Horstkorte R: The small Gtpase ras is involved in growth factor-regulated expression of the alpha1 integrin subunit in PC12 cells. Biol Chem 2001, 382:969–972.PubMedCrossRef 36. Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, Nusrat A: Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase

effectors. Am J Physiol Gastrointest Liver Physiol 2007, 292:G806-G817.PubMedCrossRef 37. Bernard O: Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 2007, 39:1071–1076.PubMedCrossRef 38. Vega FM, Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett 2008, 582:2093–2101.PubMedCrossRef 39. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S, Khanna C, Chambers AF, Green JE: Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008, check details 68:6241–6250.PubMedCrossRef 40. Tanimori Y, Tsubaki M, Yamazoe Y, Satou T, Itoh T, Kidera Y, Yanae M, Yamamoto C, Kaneko J, Nishida S: Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathway. Clin Exp Metastasis, in press. 41. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, Inoue M,

Nakamura H: 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 2002, 122:308–317.PubMedCrossRef 42. Takemura A, Nakagawa I, Kawai S, Inaba H, Kato T, Hamada S, Amano A: Inhibitory effects of tumor necrosis ASK1 factor-alpha on migration of human periodontal ligament cells. J Periodontol 2006, 77:883–890.PubMedCrossRef 43. Chan KK, Oza AM, Siu LL: The statins as anticancer agents. Clin Cancer Res 2003, 9:10–19.PubMed 44. Farina HG, Bublik DR, Alonso DF, Gomez DE: Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells. Clin Exp Metastasis 2002, 19:551–559.PubMedCrossRef 45. Sondergaard TE, Pedersen PT, Andersen TL, Søe K, Lund T, selleck products Ostergaard B, Garnero P, Delaisse JM, Plesner T: A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma. Hematol Oncol 2009, 27:17–22.PubMedCrossRef Competing interests The authors declare that they have no competing interests.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>